gaucherclinicaltrialus.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | US GuardOne Clinical |
| Description | 0 Skip to Content Patient Form Open Menu Close Menu Patient Form Open Menu Close Menu Patient Form The goal of the GuardOne Trial for Type 1 Gaucher Disea |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.185.159.144 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
gaucherclinicaltrialus.com Valuation
|
US$735
Last updated: 2022-12-13 17:11:16
gaucherclinicaltrialus.com has Semrush global rank of 0. gaucherclinicaltrialus.com has an estimated worth of US$ 735, based on its estimated Ads revenue. gaucherclinicaltrialus.com receives approximately 84 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, gaucherclinicaltrialus.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$735 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$20 |
| Yearly Ads Revenue | US$244 |
| Daily Unique Visitors | 5 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| gaucherclinicaltrialus.com. 599 | A | gaucherclinicaltrialus.com. 599 | IP: 198.185.159.144 |
| gaucherclinicaltrialus.com. 599 | A | gaucherclinicaltrialus.com. 599 | IP: 198.185.159.145 |
| gaucherclinicaltrialus.com. 599 | A | gaucherclinicaltrialus.com. 599 | IP: 198.49.23.144 |
| gaucherclinicaltrialus.com. 599 | A | gaucherclinicaltrialus.com. 599 | IP: 198.49.23.145 |
| gaucherclinicaltrialus.com. 3600 IN | NS | NS Record: ns56.domaincontrol.com. | |
| gaucherclinicaltrialus.com. 3600 IN | NS | NS Record: ns55.domaincontrol.com. | |
| gaucherclinicaltrialus.com. 3600 IN | MX | MX Record: 0 gaucherclinicaltrialus-com.mail.protection.outlook.com. | |
| gaucherclinicaltrialus.com. 3600 IN | TXT | TXT Record: v=spf1 include:secureserver.net -all | |
| gaucherclinicaltrialus.com. 3600 IN | TXT | TXT Record: facebook-domain-verification=07zhv901p9phz7hltw77f2x2ey9o4i | |
| gaucherclinicaltrialus.com. 3600 IN | TXT | TXT Record: NETORGFT6968813.onmicrosoft.com |
HtmlToTextCheckTime:2022-12-13 17:11:16
| 0 Skip to Content Patient Form Open Menu Close Menu Patient Form Open Menu Close Menu Patient Form The goal of the GuardOne Trial for Type 1 Gaucher Disease is to evaluate the safety and efficacy of an investigational medicine known as AVR-RD-02 in individuals with Type 1 Gaucher disease, who have been on stable enzyme replacement therapy (ERT) for a minimum of 24 months, OR have never received ERT or substrate reduction therapy (SRT) OR have not received ERT or SRT within the last 12 months. We are actively looking for participants between the ages of 18 and 45 years old, with a confirmed diagnosis of Type 1 Gaucher disease, and who are interested in participating in clinical trials. Interested in learning more? Complete the form below. AVR-RD-02 is an investigational medicine. Investigational medicines have not yet been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency. The safety and efficacy of AVR-RD-02 have not yet been established. Privacy |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 237539 Content-Length: 0 Date: Sat, 10 Dec 2022 14:53:18 GMT Location: https://www.gaucherclinicaltrialus.com/ Server: Squarespace Set-Cookie: crumb=BXwbrnb5NByxMzIwODJiOGM3NGYyNDg3Y2ZkYTlkZWE1N2U0MmJh;Path=/ X-Contextid: whlDPzMV/Xw7Hc1VS HTTP/2 200 accept-ranges: bytes age: 61068 content-type: text/html;charset=utf-8 date: Mon, 12 Dec 2022 15:54:29 GMT etag: W/"897b89a98849fef3aebbb349cb3dfd00--gzip" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BZOn54My2o+jZDU5OTRiMzAzYjZiNDY1MDdkYzc0ZTkxZWU0OGNi;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: EuxC29c3/Ayrz4IPC content-length: 254546 |
gaucherclinicaltrialus.com Whois Information
Domain Name: GAUCHERCLINICALTRIALUS.COM Registry Domain ID: 2552054567_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-11-16T20:01:51Z Creation Date: 2020-08-10T16:34:18Z Registry Expiry Date: 2023-08-10T16:34:18Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS55.DOMAINCONTROL.COM Name Server: NS56.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-13T08:40:47Z <<< |